Corrigendum to “Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis” [Gynecologic Oncology 162 (2021) 532–538](S0090825821005114)(10.1016/j.ygyno.2021.06.017)

Kimberly Levinson, Anna L. Beavis, Christopher Purdy, Anne F. Rositch, Akila Viswanathan, Aaron H. Wolfson, Michael G. Kelly, Krishnansu S. Tewari, Leah McNally, Saketh R. Guntupalli, Omar Ragab, Yi Chun Lee, David S. Miller, Warner K. Huh, Kelly J. Wilkinson, Nicola M. Spirtos, Linda Van Le, Yovanni Casablanca, Laura L. Holman, Steven E. WaggonerAmanda N. Fader

Research output: Contribution to journalComment/debatepeer-review

Abstract

The authors regret that the version of Table 3 originally published in this article was incorrect. The online version has now been updated and the correct table can be found below. The authors would like to apologise for any inconvenience caused. Table 3. Comparison of 3 yr RFS, nomogram recurrence risk, and Sedlis criteria for predictor variable combinations. [Table presented]

Original languageEnglish (US)
JournalGynecologic oncology
DOIs
StateAccepted/In press - 2021

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Corrigendum to “Beyond Sedlis—A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis” [Gynecologic Oncology 162 (2021) 532–538](S0090825821005114)(10.1016/j.ygyno.2021.06.017)'. Together they form a unique fingerprint.

Cite this